• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆细胞样和CD141+髓样树突状细胞在淋巴结中与CD8+ T细胞的合作与HIV控制相关。

Plasmacytoid and CD141+ Myeloid Dendritic Cells Cooperation with CD8+ T Cells in Lymph Nodes is Associated with HIV Control.

作者信息

Vitallé Joana, Bachiller Sara, Dominguez-Molina Beatriz, Moysi Eirini, Ferrando-Martínez Sara, Camacho-Sojo María Inés, Gallego Isabel, Pérez-Gómez Alberto, Jiménez-Leon María Reyes, Gasca-Capote Carmen, Ostos Francisco José, Rafii-El-Idrissi Benhnia Mohammed, Via Laura E, Mochón Antonio, López-Cortes Luis Fernando, Petrovas Constantinos, Koup Richard A, Ruiz-Mateos Ezequiel

机构信息

Institute of Biomedicine of Seville, IBiS/Virgen Del Rocío University Hospital/CSIC/University of Seville Clinical Unit of Infectious Diseases, Microbiology and Parasitology Seville Spain.

Department of Medical Biochemistry Molecular Biology, and Immunology School of Medicine University of Seville Seville Spain.

出版信息

MedComm (2020). 2025 Sep 12;6(9):e70354. doi: 10.1002/mco2.70354. eCollection 2025 Sep.

DOI:10.1002/mco2.70354
PMID:40949488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12426486/
Abstract

Dendritic cells (DC) are known to modulate antiviral immune responses; however, the knowledge about the role of different DC subsets in antiviral T cell priming in human tissues remains uncompleted. In the context of HIV infection, we determined the phenotype and location of plasmacytoid and CD141+ myeloid DCs (pDCs and mDCs) in lymph nodes of people living with HIV (PLWH). We found an interaction between pDCs and CD141+ mDCs with CD8+ T cells, being associated with participants' viral levels in blood and tissue. Moreover, we demonstrated a higher and more polyfunctional superantigen- and HIV-specific CD8+ T cell response after the coculture with Toll-like receptor (TLR)-primed pDCs and CD141+ mDCs. Last, we showed the potential of programmed cell death-1 (PD-1) blocking using pembrolizumab to further increase antigen-specific CD8+ T cell response along with TLR agonists. Therefore, these results showed a cooperation between pDCs, CD141+ mDCs and CD8+ T cells in lymph nodes of PLWH, which is associated with higher HIV control, highlighting the importance of DC subsets crosstalk to achieve a more potent anti-HIV response and support the use of DC-based immunotherapies for HIV control.

摘要

已知树突状细胞(DC)可调节抗病毒免疫反应;然而,关于不同DC亚群在人体组织中抗病毒T细胞启动过程中的作用,相关知识仍不完善。在HIV感染的背景下,我们确定了HIV感染者(PLWH)淋巴结中浆细胞样和CD141⁺ 髓样DC(pDC和mDC)的表型和位置。我们发现pDC与CD141⁺ mDC与CD8⁺ T细胞之间存在相互作用,这与参与者血液和组织中的病毒水平相关。此外,我们证明,与经Toll样受体(TLR)启动的pDC和CD141⁺ mDC共培养后,会产生更高且更具多功能性的超抗原特异性和HIV特异性CD8⁺ T细胞反应。最后,我们展示了使用派姆单抗阻断程序性细胞死亡蛋白1(PD-1)与TLR激动剂联合使用,进一步增强抗原特异性CD8⁺ T细胞反应的潜力。因此,这些结果表明PLWH淋巴结中的pDC、CD141⁺ mDC和CD8⁺ T细胞之间存在合作,这与更好的HIV控制相关,突出了DC亚群间相互作用对于实现更有效的抗HIV反应的重要性,并支持使用基于DC的免疫疗法来控制HIV。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/5d3aa6303739/MCO2-6-e70354-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/4cfd8ee9214c/MCO2-6-e70354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/2ea5f0bb1c1f/MCO2-6-e70354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/24e71cf435e1/MCO2-6-e70354-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/967ab5cf8772/MCO2-6-e70354-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/b9c679df959b/MCO2-6-e70354-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/809d834d16aa/MCO2-6-e70354-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/5d3aa6303739/MCO2-6-e70354-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/4cfd8ee9214c/MCO2-6-e70354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/2ea5f0bb1c1f/MCO2-6-e70354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/24e71cf435e1/MCO2-6-e70354-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/967ab5cf8772/MCO2-6-e70354-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/b9c679df959b/MCO2-6-e70354-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/809d834d16aa/MCO2-6-e70354-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/771e/12426486/5d3aa6303739/MCO2-6-e70354-g005.jpg

相似文献

1
Plasmacytoid and CD141+ Myeloid Dendritic Cells Cooperation with CD8+ T Cells in Lymph Nodes is Associated with HIV Control.浆细胞样和CD141+髓样树突状细胞在淋巴结中与CD8+ T细胞的合作与HIV控制相关。
MedComm (2020). 2025 Sep 12;6(9):e70354. doi: 10.1002/mco2.70354. eCollection 2025 Sep.
2
T-cell receptor/CD28-targeted immunotherapeutics selectively drive naive T-cell expansion to generate functional HIV-specific responses.靶向T细胞受体/CD28的免疫疗法可选择性地驱动初始T细胞扩增,以产生功能性HIV特异性反应。
J Virol. 2025 Aug 5:e0018825. doi: 10.1128/jvi.00188-25.
3
Innate immune dysfunction and persistent activation in South African HIV elite controllers.南非HIV精英控制者的先天性免疫功能障碍与持续激活
Front Immunol. 2025 Aug 27;16:1603436. doi: 10.3389/fimmu.2025.1603436. eCollection 2025.
4
Myeloid dendritic cells in peripheral blood correlate with the occurrence of acute graft-versus-host disease.外周血中的髓样树突状细胞与急性移植物抗宿主病的发生相关。
Eur J Med Res. 2025 Jul 5;30(1):579. doi: 10.1186/s40001-025-02872-1.
5
Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study.多替拉韦转换期间HIV-1病毒载量抑制和耐药模式:一项基于人群的纵向研究
medRxiv. 2025 Sep 2:2025.09.01.25334862. doi: 10.1101/2025.09.01.25334862.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma.cDC1与CD8+ T细胞的空间组织对黑色素瘤患者免疫检查点抑制剂反应至关重要。
Cancer Immunol Res. 2025 Apr 2;13(4):517-526. doi: 10.1158/2326-6066.CIR-24-0421.
8
Interventions for tobacco use cessation in people living with HIV.HIV 感染者的戒烟干预措施。
Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3.
9
Difference between sentinel and non-sentinel lymph nodes in the distribution of dendritic cells and macrophages: An immunohistochemical and morphometric study using gastric regional nodes obtained in sentinel node navigation surgery for early gastric cancer.前哨淋巴结与非前哨淋巴结中树突状细胞和巨噬细胞分布的差异:一项使用早期胃癌前哨淋巴结导航手术获取的胃区域淋巴结进行的免疫组织化学和形态计量学研究。
J Anat. 2025 Feb;246(2):272-287. doi: 10.1111/joa.14147. Epub 2024 Oct 5.
10
Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy.生成非同种异体反应性抗病毒中央记忆 CD8 人类效应 T 细胞用于细胞治疗。
Transplant Cell Ther. 2024 Jan;30(1):71.e1-71.e13. doi: 10.1016/j.jtct.2023.10.016. Epub 2023 Oct 26.

本文引用的文献

1
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.HTI疫苗联合TLR7激动剂用于早期治疗的HIV-1感染的安全性、免疫原性及对病毒反弹的影响:一项随机、安慰剂对照的2a期试验
Nat Commun. 2025 Mar 4;16(1):2146. doi: 10.1038/s41467-025-57284-w.
2
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial.TLR9 激动剂和广谱中和抗体对 HIV-1 持续感染的影响:随机 2a 期 TITAN 试验。
Nat Med. 2023 Oct;29(10):2547-2558. doi: 10.1038/s41591-023-02547-6. Epub 2023 Sep 11.
3
Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.
Toll 样受体激动剂增强浆细胞样树突状细胞介导的不同 HIV-1 疾病进展表型中 HIV 特异性 T 细胞反应。
EBioMedicine. 2023 May;91:104549. doi: 10.1016/j.ebiom.2023.104549. Epub 2023 Apr 3.
4
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.一种信使核糖核酸免疫原、一种Toll样受体7激动剂和一种程序性死亡受体1阻断剂的组合可增强体外HIV T细胞免疫反应。
Vaccines (Basel). 2023 Jan 28;11(2):286. doi: 10.3390/vaccines11020286.
5
XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections.XCR1+ DC 是 T 细胞介导的慢性病毒感染免疫治疗的关键。
Cell Rep. 2023 Feb 28;42(2):112123. doi: 10.1016/j.celrep.2023.112123. Epub 2023 Feb 14.
6
HIV-1 infected humanized DRAGA mice develop HIV-specific antibodies despite lack of canonical germinal centers in secondary lymphoid tissues.尽管在次级淋巴组织中缺乏典型的生发中心,HIV-1 感染的人源化 DRAGA 小鼠仍会产生 HIV 特异性抗体。
Front Immunol. 2022 Nov 25;13:1047277. doi: 10.3389/fimmu.2022.1047277. eCollection 2022.
7
Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV.抗逆转录病毒治疗持续时间和免疫代谢状态决定了基于树突状细胞的体外治疗在 HIV 感染者中恢复功能性 HIV 特异性 CD8+T 细胞疗效的作用。
EBioMedicine. 2022 Jul;81:104090. doi: 10.1016/j.ebiom.2022.104090. Epub 2022 Jun 2.
8
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques.携带SIV gp140蛋白的Ad26/MVA疫苗及维沙托利莫德在接受抗逆转录病毒治疗的恒河猴中的治疗效果
NPJ Vaccines. 2022 May 18;7(1):53. doi: 10.1038/s41541-022-00477-x.
9
HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys.HIV 包膜抗体和 TLR7 激动剂部分预防慢性 SHIV 感染猴的病毒反弹。
PLoS Pathog. 2022 Apr 22;18(4):e1010467. doi: 10.1371/journal.ppat.1010467. eCollection 2022 Apr.
10
Human dendritic cell subsets: An updated view of their ontogeny and functional specialization.人类树突状细胞亚群:其发生和功能特化的最新观点。
Eur J Immunol. 2022 Nov;52(11):1759-1767. doi: 10.1002/eji.202149632. Epub 2022 Mar 11.